The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma - Breitkreutz, Iris; Figueroa Vazquez, Vianihuini; Raab, Marc-Steffen (Annals of hematology, 2018)
Gesehen am 15.08.2019